BioCube, Inc.
BICB
$0.0002
-$0.0022-91.67%
07/31/2013 | 04/30/2013 | 01/31/2013 | 10/31/2012 | 07/31/2012 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 50.20K | 45.30K | 127.90K | 84.50K | 129.60K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 50.20K | 45.30K | 127.90K | 84.50K | 129.60K |
Operating Income | -50.20K | -45.30K | -127.90K | -84.50K | -129.60K |
Income Before Tax | -75.80K | -184.30K | -280.00K | -374.00K | -65.10K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -75.80K | -184.30K | -280.00K | -374.00K | -65.10K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -75.80K | -184.30K | -280.00K | -374.00K | -65.10K |
EBIT | -50.20K | -45.30K | -127.90K | -84.50K | -129.60K |
EBITDA | -50.20K | 102.20K | -55.50K | -58.80K | -103.80K |
EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
Average Basic Shares Outstanding | 48.78M | 48.78M | 30.90M | 32.09M | 32.38M |
Average Diluted Shares Outstanding | 48.78M | 48.78M | 30.90M | 32.09M | 32.38M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |